Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 832 entries
Sorted by: Best Match Show Resources per page
Preface. Novel targets and drugs to prevent atherogenesis and its consequences.

European journal of pharmacology

Riksen NP, Rongen GA.
PMID: 26370897
Eur J Pharmacol. 2015 Sep 15;763:1-2. doi: 10.1016/j.ejphar.2015.08.042.

No abstract available.

Cite
Riksen NP, Rongen GA. Preface. Novel targets and drugs to prevent atherogenesis and its consequences. Eur J Pharmacol. 2015;763:1-2doi: 10.1016/j.ejphar.2015.08.042.
Riksen, N. P., & Rongen, G. A. (2015). Preface. Novel targets and drugs to prevent atherogenesis and its consequences. European journal of pharmacology, 7631-2. https://doi.org/10.1016/j.ejphar.2015.08.042
Riksen, Niels P, and Rongen, Gerard A. "Preface. Novel targets and drugs to prevent atherogenesis and its consequences." European journal of pharmacology vol. 763 (2015): 1-2. doi: https://doi.org/10.1016/j.ejphar.2015.08.042
Riksen NP, Rongen GA. Preface. Novel targets and drugs to prevent atherogenesis and its consequences. Eur J Pharmacol. 2015 Sep 15;763:1-2. doi: 10.1016/j.ejphar.2015.08.042. PMID: 26370897.
Copy Download .nbib Format: NLM
Retraction notice to “Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarction in rat heart” [Eur.J.Pharmacol.January(2015)22–30].

European journal of pharmacology

[No authors listed]
PMID: 26478933
Eur J Pharmacol. 2015 Aug 15;761:423. doi: 10.1016/j.ejphar.2015.07.025.

No abstract available.

Cite
Retraction notice to “Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarction in rat heart” [Eur.J.Pharmacol.January(2015)22–30]. Eur J Pharmacol. 2015;761:423doi: 10.1016/j.ejphar.2015.07.025.
(2015). Retraction notice to “Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarction in rat heart” [Eur.J.Pharmacol.January(2015)22–30]. European journal of pharmacology, 761423. https://doi.org/10.1016/j.ejphar.2015.07.025
"Retraction notice to “Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarction in rat heart” [Eur.J.Pharmacol.January(2015)22–30]." European journal of pharmacology vol. 761 (2015): 423. doi: https://doi.org/10.1016/j.ejphar.2015.07.025
Retraction notice to “Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarction in rat heart” [Eur.J.Pharmacol.January(2015)22–30]. Eur J Pharmacol. 2015 Aug 15;761:423. doi: 10.1016/j.ejphar.2015.07.025. PMID: 26478933.
Copy Download .nbib Format: NLM
Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarctionin rat heart.

European journal of pharmacology

Pang XF, Zhang LH, Bai F, Wang NP, Ijaz Shah A, Garner R, Zhao ZQ.
PMID: 25445044
Eur J Pharmacol. 2015 Jan 05;746:22-30. doi: 10.1016/j.ejphar.2014.11.001. Epub 2014 Nov 11.

Curcumin has been shown to improve cardiac function by reducing degradation of extracellular matrix and inhibiting synthesis of collagen after ischemia. This study tested the hypothesis that attenuation of maladaptive cardiac repair with curcumin is associated with a dual...

Cite
Pang XF, Zhang LH, Bai F, et al. Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarctionin rat heart. Eur J Pharmacol. 2014;746:22-30doi: 10.1016/j.ejphar.2014.11.001.
Pang, X. F., Zhang, L. H., Bai, F., Wang, N. P., Ijaz Shah, A., Garner, R., & Zhao, Z. Q. (2015). Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarctionin rat heart. European journal of pharmacology, 74622-30. https://doi.org/10.1016/j.ejphar.2014.11.001
Pang, Xue-Fen, et al. "Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarctionin rat heart." European journal of pharmacology vol. 746 (2015): 22-30. doi: https://doi.org/10.1016/j.ejphar.2014.11.001
Pang XF, Zhang LH, Bai F, Wang NP, Ijaz Shah A, Garner R, Zhao ZQ. Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarctionin rat heart. Eur J Pharmacol. 2015 Jan 05;746:22-30. doi: 10.1016/j.ejphar.2014.11.001. Epub 2014 Nov 11. PMID: 25445044.
Copy Download .nbib Format: NLM
Corrigendum to "Restoration of sirt1 function by pterostilbene attenuates hypoxia-reoxygenation injury in cardiomyocytes" [Eur. J. Pharmacol. 776 (2016) 26-33].

European journal of pharmacology

Guo Y, Zhang L, Li F, Hu CP, Zhang Z.
PMID: 27180043
Eur J Pharmacol. 2016 Jul 05;782:120. doi: 10.1016/j.ejphar.2016.05.002.

No abstract available.

Cite
Guo Y, Zhang L, Li F, et al. Corrigendum to "Restoration of sirt1 function by pterostilbene attenuates hypoxia-reoxygenation injury in cardiomyocytes" [Eur. J. Pharmacol. 776 (2016) 26-33]. Eur J Pharmacol. 2016;782:120doi: 10.1016/j.ejphar.2016.05.002.
Guo, Y., Zhang, L., Li, F., Hu, C. P., & Zhang, Z. (2016). Corrigendum to "Restoration of sirt1 function by pterostilbene attenuates hypoxia-reoxygenation injury in cardiomyocytes" [Eur. J. Pharmacol. 776 (2016) 26-33]. European journal of pharmacology, 782120. https://doi.org/10.1016/j.ejphar.2016.05.002
Guo, Yan, et al. "Corrigendum to "Restoration of sirt1 function by pterostilbene attenuates hypoxia-reoxygenation injury in cardiomyocytes" [Eur. J. Pharmacol. 776 (2016) 26-33]." European journal of pharmacology vol. 782 (2016): 120. doi: https://doi.org/10.1016/j.ejphar.2016.05.002
Guo Y, Zhang L, Li F, Hu CP, Zhang Z. Corrigendum to "Restoration of sirt1 function by pterostilbene attenuates hypoxia-reoxygenation injury in cardiomyocytes" [Eur. J. Pharmacol. 776 (2016) 26-33]. Eur J Pharmacol. 2016 Jul 05;782:120. doi: 10.1016/j.ejphar.2016.05.002. PMID: 27180043.
Copy Download .nbib Format: NLM
Corrigendum to: Effects of L-arginine on endothelial and cardiac function in rats with heart failure.

European journal of pharmacology

Feng Q, Fortin AJ, Lu X, Arnold JM.
PMID: 10594336
Eur J Pharmacol. 1999 Nov 03;383(3):405. doi: 10.1016/s0014-2999(99)00606-8.

No abstract available.

Cite
Feng Q, Fortin AJ, Lu X, et al. Corrigendum to: Effects of L-arginine on endothelial and cardiac function in rats with heart failure. Eur J Pharmacol. 1999;383(3):405doi: 10.1016/s0014-2999(99)00606-8.
Feng, Q., Fortin, A. J., Lu, X., & Arnold, J. M. (1999). Corrigendum to: Effects of L-arginine on endothelial and cardiac function in rats with heart failure. European journal of pharmacology, 383(3), 405. https://doi.org/10.1016/s0014-2999(99)00606-8
Feng, et al. "Corrigendum to: Effects of L-arginine on endothelial and cardiac function in rats with heart failure." European journal of pharmacology vol. 383,3 (1999): 405. doi: https://doi.org/10.1016/s0014-2999(99)00606-8
Feng Q, Fortin AJ, Lu X, Arnold JM. Corrigendum to: Effects of L-arginine on endothelial and cardiac function in rats with heart failure. Eur J Pharmacol. 1999 Nov 03;383(3):405. doi: 10.1016/s0014-2999(99)00606-8. PMID: 10594336.
Copy Download .nbib Format: NLM
Preface (Festschrift david De wied).

European journal of pharmacology

Gispen WH.
PMID: 11033308
Eur J Pharmacol. 2000 Sep 29;405(1):1. doi: 10.1016/s0014-2999(00)00535-5.

No abstract available.

Cite
Gispen WH. Preface (Festschrift david De wied). Eur J Pharmacol. 2000;405(1):1doi: 10.1016/s0014-2999(00)00535-5.
Gispen, W. H. (2000). Preface (Festschrift david De wied). European journal of pharmacology, 405(1), 1. https://doi.org/10.1016/s0014-2999(00)00535-5
Gispen. "Preface (Festschrift david De wied)." European journal of pharmacology vol. 405,1 (2000): 1. doi: https://doi.org/10.1016/s0014-2999(00)00535-5
Gispen WH. Preface (Festschrift david De wied). Eur J Pharmacol. 2000 Sep 29;405(1):1. doi: 10.1016/s0014-2999(00)00535-5. PMID: 11033308.
Copy Download .nbib Format: NLM
Erratum to: "The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK(1) receptor".

European journal of pharmacology

Gouldson P, Legoux P, Carillon C, Delpech B, Le Fur G, Ferrara P, Shire D.
PMID: 11068031
Eur J Pharmacol. 2000 Nov 03;407(3):333. doi: 10.1016/s0014-2999(00)00663-4.

No abstract available.

Cite
Gouldson P, Legoux P, Carillon C, et al. Erratum to: "The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK(1) receptor". Eur J Pharmacol. 2000;407(3):333doi: 10.1016/s0014-2999(00)00663-4.
Gouldson, P., Legoux, P., Carillon, C., Delpech, B., Le Fur G, Ferrara, P., & Shire, D. (2000). Erratum to: "The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK(1) receptor". European journal of pharmacology, 407(3), 333. https://doi.org/10.1016/s0014-2999(00)00663-4
Gouldson, et al. "Erratum to: "The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK(1) receptor"." European journal of pharmacology vol. 407,3 (2000): 333. doi: https://doi.org/10.1016/s0014-2999(00)00663-4
Gouldson P, Legoux P, Carillon C, Delpech B, Le Fur G, Ferrara P, Shire D. Erratum to: "The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK(1) receptor". Eur J Pharmacol. 2000 Nov 03;407(3):333. doi: 10.1016/s0014-2999(00)00663-4. PMID: 11068031.
Copy Download .nbib Format: NLM
Erratum to 'Contribution of intestinal dipeptidyl peptidase-4 inhibition for incretin-dependent improved glucose tolerance in mice' [Eur. J. Pharmacol. 859 (2019) 172521].

European journal of pharmacology

Yamashita S, Kawakami Y, Sato H, Sugitani S, Goto M, Kato N.
PMID: 31519353
Eur J Pharmacol. 2019 Nov 05;862:172633. doi: 10.1016/j.ejphar.2019.172633. Epub 2019 Sep 10.

No abstract available.

Cite
Yamashita S, Kawakami Y, Sato H, et al. Erratum to 'Contribution of intestinal dipeptidyl peptidase-4 inhibition for incretin-dependent improved glucose tolerance in mice' [Eur. J. Pharmacol. 859 (2019) 172521]. Eur J Pharmacol. 2019;862:172633doi: 10.1016/j.ejphar.2019.172633.
Yamashita, S., Kawakami, Y., Sato, H., Sugitani, S., Goto, M., & Kato, N. (2019). Erratum to 'Contribution of intestinal dipeptidyl peptidase-4 inhibition for incretin-dependent improved glucose tolerance in mice' [Eur. J. Pharmacol. 859 (2019) 172521]. European journal of pharmacology, 862172633. https://doi.org/10.1016/j.ejphar.2019.172633
Yamashita, Satoko, et al. "Erratum to 'Contribution of intestinal dipeptidyl peptidase-4 inhibition for incretin-dependent improved glucose tolerance in mice' [Eur. J. Pharmacol. 859 (2019) 172521]." European journal of pharmacology vol. 862 (2019): 172633. doi: https://doi.org/10.1016/j.ejphar.2019.172633
Yamashita S, Kawakami Y, Sato H, Sugitani S, Goto M, Kato N. Erratum to 'Contribution of intestinal dipeptidyl peptidase-4 inhibition for incretin-dependent improved glucose tolerance in mice' [Eur. J. Pharmacol. 859 (2019) 172521]. Eur J Pharmacol. 2019 Nov 05;862:172633. doi: 10.1016/j.ejphar.2019.172633. Epub 2019 Sep 10. PMID: 31519353.
Copy Download .nbib Format: NLM
Corrigendum to "A novel flavonoid isolated from the steam-bark of Ulmus wallichiana planchon stimulates osteoblast function and inhibits osteoclast and adipocyte differentiation" [Eur. J. Pharmacol. 658(2-3) 2011 65-73].

European journal of pharmacology

Swarnkar G, Sharan K, Siddiqui J, Chakravarti B, Rawat P, Kumar M, Arya KR, Maurya R, Chattopadhyay N.
PMID: 29803358
Eur J Pharmacol. 2018 Jul 15;831:103-105. doi: 10.1016/j.ejphar.2018.05.018. Epub 2018 May 24.

No abstract available.

Cite
Swarnkar G, Sharan K, Siddiqui J, et al. Corrigendum to "A novel flavonoid isolated from the steam-bark of Ulmus wallichiana planchon stimulates osteoblast function and inhibits osteoclast and adipocyte differentiation" [Eur. J. Pharmacol. 658(2-3) 2011 65-73]. Eur J Pharmacol. 2018;831:103-105doi: 10.1016/j.ejphar.2018.05.018.
Swarnkar, G., Sharan, K., Siddiqui, J., Chakravarti, B., Rawat, P., Kumar, M., Arya, K. R., Maurya, R., & Chattopadhyay, N. (2018). Corrigendum to "A novel flavonoid isolated from the steam-bark of Ulmus wallichiana planchon stimulates osteoblast function and inhibits osteoclast and adipocyte differentiation" [Eur. J. Pharmacol. 658(2-3) 2011 65-73]. European journal of pharmacology, 831103-105. https://doi.org/10.1016/j.ejphar.2018.05.018
Swarnkar, Gaurav, et al. "Corrigendum to "A novel flavonoid isolated from the steam-bark of Ulmus wallichiana planchon stimulates osteoblast function and inhibits osteoclast and adipocyte differentiation" [Eur. J. Pharmacol. 658(2-3) 2011 65-73]." European journal of pharmacology vol. 831 (2018): 103-105. doi: https://doi.org/10.1016/j.ejphar.2018.05.018
Swarnkar G, Sharan K, Siddiqui J, Chakravarti B, Rawat P, Kumar M, Arya KR, Maurya R, Chattopadhyay N. Corrigendum to "A novel flavonoid isolated from the steam-bark of Ulmus wallichiana planchon stimulates osteoblast function and inhibits osteoclast and adipocyte differentiation" [Eur. J. Pharmacol. 658(2-3) 2011 65-73]. Eur J Pharmacol. 2018 Jul 15;831:103-105. doi: 10.1016/j.ejphar.2018.05.018. Epub 2018 May 24. PMID: 29803358.
Copy Download .nbib Format: NLM
Retraction notice to “Dual ACE-inhibition and angiotensin IIAT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarction in rat heart” [Eur.J.Pharmacol.January(2015)22–30].

European journal of pharmacology

[No authors listed]
PMID: 26331164
Eur J Pharmacol. 2015 Aug 15;761:423. doi: 10.1016/j.ejphar.2015.07.025.

No abstract available.

Cite
Retraction notice to “Dual ACE-inhibition and angiotensin IIAT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarction in rat heart” [Eur.J.Pharmacol.January(2015)22–30]. Eur J Pharmacol. 2015;761:423doi: 10.1016/j.ejphar.2015.07.025.
(2015). Retraction notice to “Dual ACE-inhibition and angiotensin IIAT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarction in rat heart” [Eur.J.Pharmacol.January(2015)22–30]. European journal of pharmacology, 761423. https://doi.org/10.1016/j.ejphar.2015.07.025
"Retraction notice to “Dual ACE-inhibition and angiotensin IIAT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarction in rat heart” [Eur.J.Pharmacol.January(2015)22–30]." European journal of pharmacology vol. 761 (2015): 423. doi: https://doi.org/10.1016/j.ejphar.2015.07.025
Retraction notice to “Dual ACE-inhibition and angiotensin IIAT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarction in rat heart” [Eur.J.Pharmacol.January(2015)22–30]. Eur J Pharmacol. 2015 Aug 15;761:423. doi: 10.1016/j.ejphar.2015.07.025. PMID: 26331164.
Copy Download .nbib Format: NLM
Corrigendum to ' Rosuvastatin inhibits pressure-induced fibrotic responses via the expression regulation of prostacyclin and prostaglandin E 2 in rat renal tubular cells.': [European Journal of Pharmacology 700 (2013) 65-73].

European journal of pharmacology

Chen CH, Cheng CY, Chen YC, Sue YM, Hsu YH, Tsai WL, Chen TH.
PMID: 29325908
Eur J Pharmacol. 2018 Jan 15;819:290. doi: 10.1016/j.ejphar.2017.12.044.

No abstract available.

Cite
Chen CH, Cheng CY, Chen YC, et al. Corrigendum to ' Rosuvastatin inhibits pressure-induced fibrotic responses via the expression regulation of prostacyclin and prostaglandin E 2 in rat renal tubular cells.': [European Journal of Pharmacology 700 (2013) 65-73]. Eur J Pharmacol. 2018;819:290doi: 10.1016/j.ejphar.2017.12.044.
Chen, C. H., Cheng, C. Y., Chen, Y. C., Sue, Y. M., Hsu, Y. H., Tsai, W. L., & Chen, T. H. (2018). Corrigendum to ' Rosuvastatin inhibits pressure-induced fibrotic responses via the expression regulation of prostacyclin and prostaglandin E 2 in rat renal tubular cells.': [European Journal of Pharmacology 700 (2013) 65-73]. European journal of pharmacology, 819290. https://doi.org/10.1016/j.ejphar.2017.12.044
Chen, Cheng-Hsien, et al. "Corrigendum to ' Rosuvastatin inhibits pressure-induced fibrotic responses via the expression regulation of prostacyclin and prostaglandin E 2 in rat renal tubular cells.': [European Journal of Pharmacology 700 (2013) 65-73]." European journal of pharmacology vol. 819 (2018): 290. doi: https://doi.org/10.1016/j.ejphar.2017.12.044
Chen CH, Cheng CY, Chen YC, Sue YM, Hsu YH, Tsai WL, Chen TH. Corrigendum to ' Rosuvastatin inhibits pressure-induced fibrotic responses via the expression regulation of prostacyclin and prostaglandin E 2 in rat renal tubular cells.': [European Journal of Pharmacology 700 (2013) 65-73]. Eur J Pharmacol. 2018 Jan 15;819:290. doi: 10.1016/j.ejphar.2017.12.044. PMID: 29325908.
Copy Download .nbib Format: NLM
Corrigendum to "Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway" [Eur. J. Pharmacol. 15 (2018) 33-39].

European journal of pharmacology

Chen W, Wu K, Zhang H, Fu X, Yao F, Yang A.
PMID: 30529035
Eur J Pharmacol. 2019 Mar 15;847:158. doi: 10.1016/j.ejphar.2018.11.042. Epub 2018 Dec 07.

No abstract available.

Cite
Chen W, Wu K, Zhang H, et al. Corrigendum to "Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway" [Eur. J. Pharmacol. 15 (2018) 33-39]. Eur J Pharmacol. 2018;847:158doi: 10.1016/j.ejphar.2018.11.042.
Chen, W., Wu, K., Zhang, H., Fu, X., Yao, F., & Yang, A. (2019). Corrigendum to "Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway" [Eur. J. Pharmacol. 15 (2018) 33-39]. European journal of pharmacology, 847158. https://doi.org/10.1016/j.ejphar.2018.11.042
Chen, Weichao, et al. "Corrigendum to "Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway" [Eur. J. Pharmacol. 15 (2018) 33-39]." European journal of pharmacology vol. 847 (2019): 158. doi: https://doi.org/10.1016/j.ejphar.2018.11.042
Chen W, Wu K, Zhang H, Fu X, Yao F, Yang A. Corrigendum to "Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway" [Eur. J. Pharmacol. 15 (2018) 33-39]. Eur J Pharmacol. 2019 Mar 15;847:158. doi: 10.1016/j.ejphar.2018.11.042. Epub 2018 Dec 07. PMID: 30529035.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 832 entries